Altimmune, Inc.

ALT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$36,926$135,117$111,097$190,301
Short-Term Investments$94,965$62,698$73,783$0
Receivables$3,117$4,853$2,541$5,839
Inventory$0$0$0$0
Other Curr. Assets$2,246$6,958$5,392$7,986
Total Curr. Assets$137,254$209,626$192,813$204,126
Property Plant & Equip (Net)$413$651$1,081$1,448
Goodwill$0$0$0$0
Intangibles$0$0$12,419$12,419
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,639$363$615$872
Total NC Assets$2,052$1,014$14,115$14,739
Other Assets$0$0$0$0
Total Assets$139,306$210,640$206,928$218,865
Liabilities
Payables$211$2,070$4,804$2,034
Short-Term Debt$279$496$452$411
Tax Payable$0$0$1,169$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$9,978$9,577$10,629$15,831
Total Curr. Liab.$10,468$12,143$17,054$18,276
LT Debt$1,402$175$672$1,124
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$3,928$4,223$3,909$330
Total NC Liab.$5,330$4,398$4,581$1,454
Other Liabilities$0$0$0$0
Cap. Leases$1,681$671$1,124$1,535
Total Liabilities$15,798$16,541$21,635$19,730
Equity
Pref Stock$0$0$0$0
Common Stock$7$7$5$4
Retained Earnings-$561,390-$466,331-$377,884-$293,171
AOCI-$4,973-$5,004-$5,227-$5,040
Other Equity$689,864$665,427$568,399$497,342
Total Equity$123,508$194,099$185,293$199,135
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$139,306$210,640$206,928$218,865
Net Debt-$35,245-$134,446-$109,973-$188,766
Altimmune, Inc. (ALT) Financial Statements & Key Stats | AlphaPilot